3i, LP 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 4:05 pm Sale | 2024-09-30 | 13G | TransCode Therapeutics, Inc. RNAZ | 3i, LP | 0 0.000% | -52,018 (Position Closed) | Filing |
| 2024-07-26 4:05 pm Purchase | 2024-07-23 | 13G | TransCode Therapeutics, Inc. RNAZ | 3i, LP | 52,018 9.900% | 52,018 (New Position) | Filing |